Vmbook Online ordering

Blackrock New York Municipal 2018 Term Trust

BlackRock Health Sciences Fund Incorporated (BLH) is a publicly traded closed-end investment company. Their investment objective is to provide long-term capital appreciation and growth of income, with current income as a secondary goal.

Being a closed-end fund, BLH has a fixed number of shares, traded on a stock exchange like an individual stock, and invests in a portfolio of stocks, bonds, or other securities.

BlackRock Health Sciences Fund is a non-diversified fund but diversifies its portfolio by investing in equities of healthcare companies worldwide that have the potential for long-term growth in revenue and earnings. Investing in health sciences companies, especially those developing or acquiring rights to new products, processes, or services, may allow it to invest in companies that are not yet profitable.

They invest in healthcare companies with potential for long-term growth in revenue and earnings, including companies engaged in research, development, production, and distribution of various medical products, services, and technologies. Investing in health sciences companies, including those that develop or acquire rights to new products, processes, or services, may allow it to invest in companies that are not yet profitable.

The fund invests in healthcare companies with long-term revenue and earnings growth potential, including pharmaceuticals, medical technology, and managed health care. These investments may also benefit from favorable U.S. and global government regulations.

BlackRock Health Sciences Fund has a gross expense ratio of 1.35%, and as of March 28, 2023, the fund has a 2.91% distribution rate, with a distribution yield of 8.18%.